Business Description
Luyan Pharma Co Ltd
ISIN : CNE1000025W1
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.11 | |||||
Equity-to-Asset | 0.26 | |||||
Debt-to-Equity | 1.56 | |||||
Debt-to-EBITDA | 7 | |||||
Interest Coverage | 3.46 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.46 | |||||
Beneish M-Score | -2.7 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6 | |||||
3-Year EBITDA Growth Rate | 8.6 | |||||
3-Year EPS without NRI Growth Rate | 9.8 | |||||
3-Year Book Growth Rate | 7.4 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 66.58 | |||||
9-Day RSI | 68.66 | |||||
14-Day RSI | 67.4 | |||||
6-1 Month Momentum % | -11.25 | |||||
12-1 Month Momentum % | -26.96 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.18 | |||||
Quick Ratio | 0.87 | |||||
Cash Ratio | 0.07 | |||||
Days Inventory | 47.5 | |||||
Days Sales Outstanding | 104.81 | |||||
Days Payable | 62.29 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.47 | |||||
Dividend Payout Ratio | 0.32 | |||||
3-Year Dividend Growth Rate | 28.9 | |||||
Forward Dividend Yield % | 3.47 | |||||
5-Year Yield-on-Cost % | 15.39 | |||||
Shareholder Yield % | 6.04 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 7.64 | |||||
Operating Margin % | 3.66 | |||||
Net Margin % | 1.81 | |||||
FCF Margin % | 3.5 | |||||
ROE % | 12.39 | |||||
ROA % | 3.11 | |||||
ROIC % | 7.3 | |||||
ROC (Joel Greenblatt) % | 10.35 | |||||
ROCE % | 18.24 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 9.4 | |||||
PE Ratio without NRI | 9.4 | |||||
Shiller PE Ratio | 9.51 | |||||
Price-to-Owner-Earnings | 39.05 | |||||
PEG Ratio | 0.83 | |||||
PS Ratio | 0.18 | |||||
PB Ratio | 1.09 | |||||
Price-to-Tangible-Book | 1.38 | |||||
Price-to-Free-Cash-Flow | 4.8 | |||||
Price-to-Operating-Cash-Flow | 2.86 | |||||
EV-to-EBIT | 11.04 | |||||
EV-to-EBITDA | 11.04 | |||||
EV-to-Revenue | 0.38 | |||||
EV-to-FCF | 10.92 | |||||
Price-to-Projected-FCF | 1.63 | |||||
Price-to-DCF (Earnings Based) | 0.53 | |||||
Price-to-DCF (FCF Based) | 0.38 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.38 | |||||
Price-to-Graham-Number | 0.76 | |||||
Price-to-Net-Current-Asset-Value | 6.08 | |||||
Earnings Yield (Greenblatt) % | 9.06 | |||||
FCF Yield % | 20.7 | |||||
Forward Rate of Return (Yacktman) % | 5.69 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Luyan Pharma Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 20,127.318 | ||
EPS (TTM) (Â¥) | 0.931 | ||
Beta | 0.88 | ||
Volatility % | 30.49 | ||
14-Day RSI | 67.4 | ||
14-Day ATR (Â¥) | 0.323395 | ||
20-Day SMA (Â¥) | 7.631 | ||
12-1 Month Momentum % | -26.96 | ||
52-Week Range (Â¥) | 6.1 - 10.19 | ||
Shares Outstanding (Mil) | 388.52 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Luyan Pharma Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Luyan Pharma Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Luyan Pharma Co Ltd Frequently Asked Questions
What is Luyan Pharma Co Ltd(SZSE:002788)'s stock price today?
When is next earnings date of Luyan Pharma Co Ltd(SZSE:002788)?
Does Luyan Pharma Co Ltd(SZSE:002788) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |